Researchers at Kyoto University Hospital in Japan, led by Dr. Katsu Takahashi, have begun human trials on a groundbreaking antibody treatment that could enable people to regrow teeth. The treatment works by blocking a protein called USAG-1, which typically prevents new tooth formation.
In earlier animal studies, the antibody successfully stimulated the natural growth of new teeth within weeks, showing promising results for potential use in humans. The ongoing clinical trials aim to assess the safety and effectiveness of the treatment before it can become widely available.
If successful, this innovation could revolutionize dentistry by offering a natural alternative to implants and dentures, helping individuals who have lost teeth due to injury, decay, or genetic conditions.
